毕得医药实控人戴岚拟减持不超14.88万股公司股份

Core Points - Bid Pharma (688073) announced a plan for its controlling shareholder, Dai Lan, to reduce his stake in the company due to personal financial needs [1] - The reduction will occur within three months after the disclosure of the plan, with a maximum of 148,800 shares to be sold, representing 0.16% of the total share capital [1] - Dai Lan currently holds 29,664,700 shares, accounting for 32.64% of the total shares of Bid Pharma [1]